CoChat
Sign Up
Cited by 394Maternal Mental Health During Pregnancy and PostpartumBipolar Disorder and TreatmentPregnancy and Medication Impact

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Management of Bipolar Disorder During Pregnancy and the Postpartum Period

Yonkers, Kimberly A., Wisner, Katherine L., Stowe, Zachary, Leibenluft, Ellen, Cohen, Lee, Miller, Laura, Manber, Rachel, Viguera, Adele, Suppes, Trisha, Altshuler, Lori·2004·American Journal of Psychiatry
DOI 10.1176/appi.ajp.161.4.608
Open this paper in CoChat — free account

Abstract

OBJECTIVE: Bipolar disorder affects 0.5%-1.5% of individuals in the United States. The typical age at onset is late adolescence or early adulthood, placing women at risk for episodes throughout their reproductive years. General guidelines for the treatment of bipolar disorder are available from the American Psychiatric Association, but additional issues arise when these guidelines are applied in the treatment of peripartum women. The authors summarize knowledge regarding the management of bipolar disorder during pregnancy and the postpartum period, with a focus on managing mania, hypomania, and the psychotic components of the illness. METHOD: An expert panel reviewed articles that address the management of bipolar disorder and the consequences of the use of mood stabilizers during pregnancy, and a consensus document was generated. RESULTS: The treatment of bipolar disorder in pregnant women involves significant challenges. Some mood stabilizers, e.g., sodium valproate and carbamazepine, are human teratogens. On the other hand, the teratogenicity associated with lithium may have been overestimated in the past. CONCLUSIONS: Since treatment can be managed most effectively if pregnancy is planned, clinicians should discuss the issue of pregnancy and its management with every bipolar disorder patient who has childbearing potential, regardless of future reproductive plans. Additional research should address the risks of disturbed sleep to pregnant and postpartum women with bipolar disorder, as well as structural and behavioral consequences to offspring when mood stabilizers are used during pregnancy. Longitudinal and cohort studies can promote these efforts. Given the rate of bipolar disorder in the general population, research efforts will need to be broad based and include multiple collaborating centers.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.161.4.608

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Delgado-Escueta A, Janz D: Consensus guidelines: preconception counseling, management, and care of pregnant women with epilepsy. Neurology 1992; 42:149–160
  2. Crawford P, Appleton R, Betts T, Duncan J, Guthrie E, Morrow J (Women With Epilepsy Guidelines Development Group): Best practice guidelines for the management of women with epilepsy. Seizure 1999; 8:201–217 · DOI

Cited by

Sorted by citations

See all 394

Related

See all

Metadata

Authors
Yonkers, K. A., Wisner, K. L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., Manber, R., Viguera, A., Suppes, T., & Altshuler, L.
Affiliations
Yale University (US)
ORCID
Venue
American Journal of Psychiatry
Publisher
American Psychiatric Association Publishing
Published
2004-04-01
Volume
161
Issue
4
Pages
608-620
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
DOI
10.1176/appi.ajp.161.4.608
OpenAlex
W2124391299
Cited by
394
References
106
Citations by year
2026: 5 · 2025: 7 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 11 · 2020: 8 · 2019: 11 · 2018: 16 · 2017: 15 · 2016: 23 · 2015: 22 · 2014: 30 · 2013: 22 · 2012: 24
FWCI
23.19
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
bipolar disorder, pregnancy, postpartum period, peripartum women, mania, hypomania, psychosis, mood stabilizers, lithium, valproic acid, carbamazepine, teratogenicity, pregnancy planning, sleep disorders, offspring outcomes
MeSH terms
Lamotrigine, Adolescent, Adult, Anticonvulsants, Bipolar Disorder, Carbamazepine, Female, Embryonic and Fetal Development, Fetal Diseases, Humans, Pregnancy, Prenatal Exposure Delayed Effects, Antipsychotic Agents, Triazines, Valproic Acid, Lithium Carbonate, Antimanic Agents, Postpartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review